Intercure (TSX:INCR.U) Total Tax Payable : $0.00 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Intercure Total Tax Payable?

Intercure's Total Tax Payable for the quarter that ended in Jun. 2024 was $0.00 Mil.

Intercure Total Tax Payable Historical Data

The historical data trend for Intercure's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intercure Total Tax Payable Chart

Intercure Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

Intercure Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Jun24
Total Tax Payable	Get a 7-Day Free Trial															-	-	-	-	-

Intercure Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Intercure Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Intercure's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Intercure Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intercure Ltd (TSX:INCR.U) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

INCR:USA INCR:Israel

Address

85 Medinat ha-Yehudim Street, Herzliya, ISR, 4676670

Website

https://www.intercure.co

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.

Intercure Headlines

No Headlines